Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
19.3%
% of WDNA's 91 holdings also in IDNA
37.8%
% of IDNA's 49 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
TWIST BIOSCIENCE CORP. | 4.3% | 3.1% | 3.1% | |
GERON CORP | 2.5% | 2.3% | 2.3% | |
IOVANCE BIOTHERAPEUTICS INC | 1.7% | 2.1% | 1.7% | |
SAREPTA THERAPEUTICS INC | 1.7% | 4.2% | 1.7% | |
BLUEPRINT MEDICINES CORP. | 2.6% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to IDNA
NOVOZYMES A/S-B SHARES | 2.7% | |
AGIOS PHARMACEUTICALS INC | 2.4% | |
FATE THERAPEUTICS INC | 2.2% | |
NATERA INC | 2.2% | |
VERICEL CORPORATION | 2.1% | |
ELI LILLY & CO | 2.1% | |
BRIDGEBIO PHARMA, INC. | 1.6% | |
VERTEX PHARMACEUTICALS INC | 1.6% | |
UNITED THERAPEUTICS CORP | 1.5% | |
IONIS PHARMACEUTICALS, INC. | 1.4% |
WDNA Underweight Relative to IDNA
EXELIXIS INC | -6.7% | |
GILEAD SCIENCES INC | -4.9% | |
INCYTE CORP | -4.9% | |
BEIGENE, LTD. | -4.8% | |
REVOLUTION MEDICINES, INC. | -4.7% | |
ROCHE HOLDING LTD | -4.4% | |
BIONTECH SE SPONSORED ADR | -4.2% | |
SANOFI-AVENTIS | -4.0% | |
ARCELLX, INC. | -3.9% | |
GSK PLC | -3.4% |